跳至主要内容
临床试验/ACTRN12618001642279
ACTRN12618001642279已完成未知

A randomised controlled trial comparing the cost and clinical effectiveness of midline to PICC for delivering intravenous antibiotics to children requiring intensive pulmonary optimisation.

Griffith University0 个研究点目标入组 109 人开始时间: 2018年10月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
109

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
Years 至 18 Years(—)
性别
All

入选标准

  • . Respiratory diagnosis of CF or any other respiratory diagnosis including, non-CF bronchiectasis
  • 0 (>37 weeks) – 18 years of age (17 years + 364 days)
  • Referred to the vascular assessment and management service (VAMS) for insertion of a vascular access device to facilitate antibiotic therapy for pulmonary optimisation.
  • Infusates deemed compatible with peripheral/midline administration based on assessment of venous infusion extravasation risk
  • English speaking
  • Able to provide consent

排除标准

  • Non-english speaking parent
  • Unable to provide consent
  • Previous enrolment in current trial
  • Thrombosis at level of axillar or sub-clavian that precludes insertion of midline or PICC
  • - Medical diagnosis of behavioural condition. e.g. autism, ADHD that would make it impossible for a child to co-operate to a level necessary to have the device inserted with anaesthesia.

研究者

相似试验